BioAge Labs News, BioAge Labs Quote, BIOA Quote

BioAge Labs (NQ:BIOA) Delayed: 20.77 +0.78 (3.90%)

Prev. Close

$19.99

Today 6M 1Y 5Y

Open

$20.53

52 Wk High

$8.73

52 Wk Low

$2.86

Day High

$20.94

Day Low

$19.32

P/E

N/A

EPS

$-3.82

Volume

619,617

Friends, Peers and Foes (?): B, BIOA-B.ST, BIOAB, BIOA-B, BIOAB.ST (more...)

ALERTS | RSS

Jun 16, 2026 08:00 AM BioAge Labs begins Phase 2 trial of NLRP3 inhibitor BGE-102
Jun 16, 2026 08:00 AM BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
Jun 12, 2026 04:37 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Pande Vijay Satyanand
Jun 12, 2026 04:36 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Hemrajani Rekha
Jun 12, 2026 04:34 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: HEALY JAMES
Jun 12, 2026 04:33 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: ENRIGHT PATRICK G
Jun 12, 2026 04:32 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Davidson Michael H.
Jun 12, 2026 04:29 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: GARNIER JEAN PIERRE
Jun 12, 2026 08:00 AM Form 8-K BioAge Labs, Inc. For: Jun 10
May 30, 2026 04:32 AM Number of shares and votes in BioArctic AB (publ) as of May 29, 2026

Entities mentioned with BIOA

View All Entities